Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
1481 results found
2023 ∙ Di Vincenzo, F. Ennas, S. Pizzoferrato, M. Bibbò, S. Porcari, S. Ianiro, G. Cammarota, G.
Henoch-schonlein purpura following exposure to SARS-CoV2 vaccine or infection: a systematic review and a case report
Children Adolescents Adults COVID-19 Safety
Rating:
Critically low
2023 ∙ Shafiee, A. Amini, M. J. Arabzadeh Bahri, R. Jafarabady, K. Salehi, S. A. Hajishah, H. Mozhgani, S. H.
Herpesviruses reactivation following COVID-19 vaccination: a systematic review and meta-analysis
Adults Older adults COVID-19 Safety
Rating:
Critically low
2023 ∙ Cazzato, G. Ambrogio, F. Pisani, M. C. Colagrande, A. Arezzo, F. Cascardi, E. Dellino, M. Macorano, E. Trilli, I. Parente, P. Lettini, T. Romita, P. Marzullo, A. Ingravallo, G. Foti, C.
Histopathological Patterns of Cutaneous Adverse Reaction to Anti-SARS-CoV-2 Vaccines: The Integrative Role of Skin Biopsy
All age groups COVID-19 Safety
Rating:
Critically low
2023 ∙ Limbu, Y. B. Gautam, R. K.
How Well the Constructs of Health Belief Model Predict Vaccination Intention: A Systematic Review on COVID-19 Primary Series and Booster Vaccines
All age groups Healthcare workers Parents/caregivers COVID-19 Acceptance
Rating:
Not applicable
2023 ∙ Alotaibi, A. S. Shalabi, H. A. Alhifany, A. A. Alotaibi, N. E. Alnuhait, M. A. Altheaby, A. R. Alhazmi, A. Y.
Humoral and Cellular Immunity following Five Doses of COVID-19 Vaccines in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis
Adults Older adults COVID-19 Efficacy/effectiveness
Rating:
Not applicable
2023 ∙ Farhadian, N. Sharifi, S. Taghadosi, M. Farhadian, M. Vaziri, S.
Humoral immune response to two doses of COVID-19 mRNA-based vaccines in people living with HIV: A systematic review and meta-analysis
Adults COVID-19 Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Martinelli, S. Pascucci, D. Laurenti, P.
Humoral response after a fourth dose of SARS-CoV-2 vaccine in immunocompromised patients. Results of a systematic review
Adults Older adults COVID-19 Efficacy/effectiveness Safety
Rating:
Critically low
2023 ∙ Notarte, K. I. Catahay, J. A. Peligro, P. J. Velasco, J. V. Ver, A. T. Guerrero, J. J. Liu, J. Lippi, G. Benoit, S. W. Henry, B. M. Fernández-de-Las-Peñas, C.
Humoral Response in Hemodialysis Patients Post-SARS-CoV-2 mRNA Vaccination: A Systematic Review of Literature
All age groups COVID-19 Efficacy/effectiveness
Rating:
Low
2023 ∙ Camargo-Coronel, A. Quiñones-Moya, H. Hernández-Zavala, M. R. Hernández-Vázquez, J. R. Vázquez-Zaragoza, MÁ
Idiopathic inflammatory myopathies linked to vaccination against SARS-CoV-2: a systematic review
Adults Older adults COVID-19 Safety
Rating:
Critically low
2023 ∙ Shi, H. Sun, J. Zeng, Y. Wang, X. Liu, S. Zhang, L. Shao, E.
Immune escape of SARS-CoV-2 variants to therapeutic monoclonal antibodies: a system review and meta-analysis
Adults Older adults COVID-19 Efficacy/effectiveness Administration
Rating:
Critically low
Loading...